|
1
|
Basu-Roy U, Basilico C and Mansukhani A:
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett.
338:158–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin PP and Patel S: Osteosarcoma. Bone
Sarcoma Springer. 75–97. 2013. View Article : Google Scholar
|
|
3
|
Di Fiore R, Guercio A, Puleio R, Di Marco
P, Drago-Ferrante R, D'Anneo A, De Blasio A, Carlisi D, Di Bella S,
Pentimalli F, et al: Modeling human osteosarcoma in mice through
3AB-OS cancer stem cell xenografts. J Cell Biochem. 113:3380–3392.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ren Z, Liang S, Yang J, Han X, Shan L,
Wang B, Mu T, Zhang Y, Yang X, Xiong S and Wang G: Coexpression of
CXCR4 and MMP9 predicts lung metastasis and poor prognosis in
resected osteosarcoma. Tumor Biol. 37:5089–5096. 2016. View Article : Google Scholar
|
|
7
|
Meazza C and Scanagatta P: Metastatic
osteosarcoma: A challenging multidisciplinary treatment. Expert Rev
Anticancer Ther. 16:543–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng Q, Zheng M, Liu H, Song C, Zhang W,
Yan J, Qin L and Liu X: SASH1 regulates proliferation, apoptosis,
and invasion of osteosarcoma cell. Mol Cell Biochem. 373:201–210.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo H, Zou J, Dong Z, Zeng Q, Wu D and Liu
L: Up-regulated miR-17 promotes cell proliferation, tumour growth
and cell cycle progression by targeting the RND3 tumour suppressor
gene in colorectal carcinoma. Biochem J. 442:311–321. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martini M, Gnann A, Scheikl D, Holzmann B
and Janssen KP: The candidate tumor suppressor SASH1 interacts with
the actin cytoskeleton and stimulates cell-matrix adhesion. Int J
Biochem Cell Biol. 43:1630–1640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Fu W, Wo L, Shu X, Liu F and Li C:
miR-128 and its target genes in tumorigenesis and metastasis. Exp
Cell Res. 319:3059–3064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun X, Yang Z, Zhang Y, He J, Wang F, Su
P, Han J, Song Z and Fei Y: Prognostic implications of tissue and
serum levels of microRNA-128 in human prostate cancer. Int J Clin
Exp Pathol. 8:8394–8401. 2015.PubMed/NCBI
|
|
16
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Botter SM, Neri D and Fuchs B: Recent
advances in osteosarcoma. Curr Opin Pharmacol. 16:15–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen L, Chen XD and Zhang YH: MicroRNA-128
promotes proliferation in osteosarcoma cells by downregulating
PTEN. Tumor Biol. 35:2069–2074. 2014. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
21
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human microRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basuroy U, Basilico C and Mansukhani A:
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett.
338:158–167. 2011. View Article : Google Scholar
|
|
24
|
Zwaga T, Bovée JV and Kroon HM:
Osteosarcoma of the femur with skip, lymph node, and lung
metastases. Radiographics. 28:277–283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu YD, Wang L, Sun C, Fan L, Zhu DX, Fang
C, Wang YH, Zou ZJ, Zhang SJ, Li JY and Xu W: Distinctive microRNA
signature is associated with the diagnosis and prognosis of acute
leukemia. Med Oncol. 29:2323–2331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roth P, Wischhusen J, Happold C, Chandran
PA, Hofer S, Eisele G, Weller M and Keller A: A specific miRNA
signature in the peripheral blood of glioblastoma patients. J
Neurochem. 118:449–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pang CS, Kwok WK, Chen Z and Ng HK:
Oncogenic role of microRNAs in brain tumors. Acta Neuropathol.
117:599–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: MicroRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
29
|
Woo HH, László CF, Greco S and Chambers
SK: Regulation of colony stimulating factor-1 expression and
ovarian cancer cell behavior in vitro by miR-128 and miR-152. Mol
Cancer. 11:582012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rimkus C, Martini M, Friederichs J,
Rosenberg R, Doll D, Siewert JR, Holzmann B and Janssen KP:
Prognostic significance of downregulated expression of the
candidate tumour suppressor gene SASH1 in colon cancer. Br J
Cancer. 95:1419–1423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen H, Wang D and Liu Y: SASH1 inhibits
cervical cancer cell proliferation and invasion by suppressing the
FAK pathway. Mol Med Rep. 13:3613–3618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He P, Zhang HX, Sun CY, Chen CY and Jiang
HQ: Overexpression of SASH1 inhibits the proliferation, invasion,
and EMT in hepatocarcinoma cells. Oncol Res. 24:25–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Delbridge ARD and Strasser A: The BCL-2
protein family, BH3-mimetics and cancer therapy. Cell Death Differ.
22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Czabotar PE, Westphal D, Dewson G, Ma S,
Hockings C, Fairlie WD, Lee EF, Yao S, Robin AY, Smith BJ, et al:
Bax crystal structures reveal how BH3 domains activate Bax and
nucleate its oligomerization to induce apoptosis. Cell.
152:519–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
